If Hairgenetix doesn’t deliver results in 4 months, get a full refund in just 3 simple steps.
Trusted by hundreds and rated
With an 'Excellent' rating of 4.6 stars, based on over 1,200 reviews, our customers' trust in Hairgenetix reflects the remarkable results you can achieve with our hair growth products.
Our products are third-party clinically tested
In a 150-day clinical trial involving 30 men and women aged 18–65 with diverse types of hair loss, the Hairgenetix serum achieved a clinically proven 93% reduction in hair shedding.
Microneedling for Hair Loss: What a Meta-Analysis of Multiple Studies Found (2022)
Posted by Aditya K. Gupta, Emma M. Quinlan et al. on March 05, 2026
Key Findings at a Glance
Microneedling alone beats minoxidil 5%: Microneedling monotherapy produced significantly more hair growth than the gold-standard topical treatment (β = 12.29, p < 0.001)
Combination is even more effective: Adding minoxidil to microneedling further improved results beyond microneedling alone (β = 7.63, p < 0.05)
Longer treatment = better results: Increasing overall treatment duration was positively associated with greater hair count improvements
Less frequent sessions may be better: Reducing session frequency (e.g., fortnightly vs weekly) showed a positive trend towards better outcomes
Highest-level evidence: This meta-analysis pooled data from multiple independent clinical trials using multivariable regression, representing the strongest form of evidence
Evidence Summary
Study Design
Systematic review and meta-analysis with multivariable linear regression
Data Sources
Multiple clinical trials investigating microneedling for androgenetic alopecia
Medical Disclaimer: This article summarises published clinical research for educational purposes only. It is not medical advice. Always consult a qualified healthcare professional before starting any hair loss treatment. Individual results may vary from those reported in clinical trials.
Reviewed by: Esther Bodde, MD — Physician and medical content reviewer at Hairgenetix. Dr. Bodde ensures all clinical research summaries accurately represent the original study data, methodology, and conclusions.
Why This Research Matters
By 2021, nearly a decade of clinical trials had been published testing microneedling for hair loss — from the landmark Dhurat 2013 study through dozens of subsequent trials. Each study told part of the story, but no single trial could answer the big picture question: across all available evidence, does microneedling really work, and how does it compare to established treatments?
That is exactly what Gupta et al. set out to answer. Their meta-analysis pooled data from multiple clinical trials and used multivariable linear regression — a statistical method that controls for confounding variables — to extract the clearest possible signal from the noise. The result was a definitive answer: microneedling is not just a useful add-on; it outperforms the gold-standard topical treatment (minoxidil 5%) as a standalone therapy.
This matters because it shifts microneedling from being seen as an "optional extra" to being recognised as a primary treatment option for androgenetic alopecia. For patients who cannot tolerate minoxidil, or who prefer a non-pharmaceutical approach, this meta-analysis provides the highest level of evidence supporting microneedling as a legitimate first-line treatment.
What The Researchers Did
The research team at the University of Toronto conducted a systematic literature search to identify all clinical trials that had tested microneedling for androgenetic alopecia (AGA). They followed established protocols to ensure no relevant studies were missed.
Once they had assembled the full body of evidence, they applied multivariable linear regression analysis to the pooled data. This is a sophisticated statistical approach that goes beyond simply averaging results — it analyses multiple variables simultaneously and isolates the independent effect of each treatment while controlling for factors that might distort the comparison.
The analysis compared three treatment approaches:
Comparison
What It Tests
Microneedling vs minoxidil 5%
Does microneedling alone produce more hair growth than the standard topical treatment?
Microneedling + minoxidil vs microneedling alone
Does adding minoxidil to microneedling further improve results?
Treatment duration and frequency
Do longer treatments and different session frequencies affect the outcome?
The researchers also examined moderating variables including needle depth, treatment frequency, and overall duration — asking not just whether microneedling works, but how to optimise it.
What Is a Meta-Analysis With Multivariable Regression?
A meta-analysis is the highest level of clinical evidence. It pools data from multiple independent studies — each with its own patients, methods, and researchers — into a single statistical analysis. Think of it as combining the puzzle pieces from many different boxes to see the complete picture.
Multivariable regression adds an extra layer of rigour. Instead of simply averaging the results, it builds a mathematical model that accounts for multiple variables at once (e.g., needle depth, frequency, treatment duration, minoxidil use). This lets researchers isolate the effect of each variable independently. For example, it can determine whether microneedling's benefit is real even after accounting for differences in study duration or minoxidil concentration.
The beta coefficient (β) represents the size of the effect. A positive β means the treatment increased hair count; the larger the number, the greater the effect. The p-value tells us how confident we can be: p < 0.001 means there is less than a 0.1% chance the result occurred by random chance.
What They Found
1. Microneedling alone outperforms minoxidil 5%
Finding: Microneedling as monotherapy significantly increased total hair count more than topical minoxidil 5%, with a regression coefficient of β = 12.29 (p < 0.001). This means microneedling alone produced approximately 12.3 additional hairs per cm² compared to minoxidil alone, after controlling for other variables.
This is the headline finding — and it is remarkable. Minoxidil has been the gold-standard topical treatment for androgenetic alopecia for over three decades. The fact that a physical treatment (creating micro-injuries in the scalp) outperforms the most widely prescribed topical medication challenges conventional treatment hierarchies.
The p-value of less than 0.001 makes this one of the most statistically robust findings in the hair loss treatment literature. There is less than a 0.1% probability that this result is due to chance.
2. Combining microneedling with minoxidil is even more effective
Finding: Adding minoxidil 5% to microneedling further increased hair count beyond microneedling alone (β = 7.63, p < 0.05). The combination therapy produced approximately 7.6 additional hairs per cm² compared to microneedling monotherapy.
This confirms that microneedling and minoxidil have complementary mechanisms. Microneedling creates the micro-channels and triggers growth factor release, while minoxidil stimulates follicles through vasodilation and prolonged growth phase. Using both together produces an additive benefit — as demonstrated in the original Dhurat 2013 trial and now confirmed across multiple pooled studies.
3. Longer treatment duration improves outcomes
Finding: Increasing the overall treatment duration was positively associated with greater hair count improvements. Patients who continued microneedling for longer periods experienced better results than those in shorter trials.
This suggests that microneedling's benefits are cumulative. Unlike some treatments that plateau quickly, microneedling appears to continue producing improvements with sustained use. This aligns with the biology: repeated stimulation of the wound healing cascade and growth factor release compounds over time.
4. Less frequent sessions may be more effective
Finding: Reducing microneedling session frequency (e.g., fortnightly rather than weekly) showed a positive influence on treatment outcomes. More frequent sessions did not necessarily produce better results.
This counterintuitive finding is biologically plausible. Microneedling triggers a wound healing cascade that requires time to complete. If sessions are too frequent, the scalp may not fully recover between treatments, potentially blunting the regenerative response. Allowing adequate healing time between sessions may produce a stronger growth factor surge with each treatment.
The Faghihi et al. 2021 study found similarly that more aggressive parameters are not necessarily better — shallower needle depths performed equally well as deeper ones.
Figure 1. Key findings from Gupta et al. (2022) meta-analysis — regression analysis of microneedling efficacy for androgenetic alopecia. Data source: Journal of Cosmetic Dermatology, Vol. 21(1), pp. 108–117 (PMID: 34714971).
Why Microneedling Works: The Science Behind the Results
1. Growth factor release through controlled injury
Every microneedling session creates thousands of micro-injuries that activate the body's wound healing cascade. This releases platelet-derived growth factor (PDGF), vascular endothelial growth factor (VEGF), epidermal growth factor (EGF), and fibroblast growth factor (FGF). These growth factors directly stimulate dermal papilla cells — the specialised cells that control the hair growth cycle — pushing dormant follicles into the active growth phase (anagen).
2. Stem cell activation via Wnt signalling
Microneedling activates the Wnt/β-catenin signalling pathway, a key molecular switch for hair follicle stem cell activation. This may explain why microneedling works even as a monotherapy: it recruits dormant stem cells through a mechanism entirely different from how minoxidil works, explaining why the two treatments are additive rather than redundant.
3. Enhanced drug delivery
For combination therapy, microneedling creates temporary channels through the stratum corneum (skin barrier), allowing topical treatments to penetrate 5–10× deeper into the follicle than surface application. This is why adding minoxidil to microneedling produces additional benefit (β = 7.63): the microneedling literally delivers more of the drug to where it needs to go.
4. Neovascularisation
The healing response stimulates new blood vessel formation (angiogenesis) around hair follicles, improving nutrient delivery. This complements both minoxidil's vasodilatory effect and the blood vessel-promoting properties of peptides like GHK-Cu, which affects 31.2% of human genes including those governing vascular remodelling.
Putting the Numbers in Context
The beta coefficients from this meta-analysis represent the independent effect of each treatment after controlling for confounding variables. Here is how to interpret them:
Comparison
β Coefficient
p-Value
What It Means
Microneedling vs minoxidil 5%
+12.29
< 0.001
Microneedling produces ~12 more hairs/cm² than minoxidil alone
MN + minoxidil vs MN alone
+7.63
< 0.05
Adding minoxidil to MN adds ~8 more hairs/cm²
Combined, these findings suggest that microneedling + minoxidil produces approximately 20 more hairs per cm² than minoxidil alone — a finding broadly consistent with individual trials like Dhurat et al. (2013), which found a 4× improvement, and Pei et al. (2024), which confirmed statistically significant superiority across 1,458 patients.
The regression coefficients are more conservative than individual study results because they control for confounding variables. The Dhurat study's dramatic +91.4 vs +22.2 hairs/cm² result likely reflects specific study conditions (population, needle depth, compliance). The meta-analysis distils the average effect across diverse conditions — providing a more generalisable estimate of what a typical patient might expect.
How This Study Compares to Other Meta-Analyses
Meta-Analysis
Year
Studies
Patients
Key Finding
Gupta et al. (this study)
2022
Multiple RCTs
Pooled
MN > minoxidil (β = 12.29, p < 0.001); MN + minoxidil even better
Minoxidil + MN significantly superior to minoxidil alone
Every meta-analysis conducted since 2022 has confirmed the same conclusion: microneedling, alone or in combination with topical treatment, produces significantly better outcomes than topical treatment alone. The consistency of this finding across different research groups, statistical methods, and patient populations makes it one of the most robust conclusions in the hair loss treatment literature.
Treatment Parameter Insights From This Meta-Analysis
Parameter
Finding
Implication
Treatment Duration
Longer duration positively associated with better outcomes
Commit to at least 12–24 weeks for optimal results
Session Frequency
Reducing frequency may positively influence outcomes
Fortnightly sessions may work as well as or better than weekly
Needle Depth
Studies used various depths (0.5–2.5 mm)
1.0–1.5 mm is the most commonly studied clinical depth
Combination vs Monotherapy
Combination with minoxidil adds β = 7.63 (p < 0.05)
Best results come from combining microneedling with topical treatments
Important: Microneedling at clinical depths (1.0+ mm) should be performed by or under the guidance of a healthcare professional. At-home devices typically use shorter needles (0.25–0.5 mm). Always consult your dermatologist about the appropriate protocol for your situation.
Research Limitations
Limited monotherapy studies: The authors specifically noted that few studies investigate microneedling as a standalone treatment — most trials combine it with minoxidil or other topicals. This makes the monotherapy regression coefficient less robust than the combination finding
Heterogeneity in protocols: The included studies used different needle depths (0.5–2.5 mm), frequencies (weekly to monthly), devices (dermaroller, dermapen, fractional radiofrequency), and treatment durations, which adds variability to the pooled analysis
Primarily male populations: Most included studies focused on male androgenetic alopecia. The findings cannot be directly extrapolated to female pattern hair loss without dedicated meta-analyses
No standardised outcome measures: Different studies used different methods to count hairs (phototrichogram, TrichoScan, clinical photography), making direct comparison imprecise
Publication bias risk: Studies showing positive results are more likely to be published than negative ones, which could inflate the apparent effect size
Need for larger RCTs: The authors themselves call for larger randomised controlled trials with standardised protocols to establish optimal treatment parameters
What This Means for Your Hair
This meta-analysis provides the strongest evidence to date that microneedling should be considered a primary treatment for androgenetic alopecia — not just an add-on to existing therapies. Here is what this means in practical terms:
If you are currently using minoxidil alone: Adding microneedling is likely to significantly improve your results. The combination effect (β = 7.63) is statistically significant and has been confirmed by every subsequent meta-analysis.
If you cannot use or tolerate minoxidil: Microneedling as monotherapy may be a viable alternative. The meta-analysis found it outperforms minoxidil 5% (β = 12.29, p < 0.001), though more monotherapy studies are needed to fully establish optimal standalone protocols.
If you want to optimise your microneedling protocol: The data suggests that longer treatment duration (3–6 months minimum) and less aggressive session frequency (fortnightly rather than weekly) may actually produce better results than trying to do more, more often.
For the most evidence-based approach, combine microneedling with proven topical formulations. The micro-channels created by microneedling dramatically enhance absorption of active ingredients. Research on AHK-Cu copper peptides and GHK-Cu shows these ingredients work through complementary biological pathways, and the Kuceki et al. 2025 study specifically demonstrated that combining microneedling with copper peptide formulations produced significant improvement in treatment-resistant alopecia.
Key Terms Explained
Meta-Analysis
A statistical technique that combines results from multiple independent studies into a single analysis. By pooling data, it increases statistical power and produces more reliable conclusions than any individual study. Meta-analyses sit at the top of the evidence hierarchy in medicine.
Multivariable Linear Regression
A statistical method that analyses the relationship between multiple variables simultaneously. In this study, it isolates the independent effect of microneedling on hair count while controlling for differences in study design, duration, and other factors that might confound the comparison.
Beta Coefficient (β)
A number from the regression model that represents the size and direction of an effect. A positive β means the treatment increased hair count; the larger the number, the greater the improvement. β = 12.29 means approximately 12.3 additional hairs per cm² attributable to microneedling.
p-Value
The probability that the observed result occurred by random chance alone. A p-value of < 0.001 means there is less than a 0.1% chance the finding is due to chance — making it highly statistically significant. The conventional threshold for significance is p < 0.05 (less than 5% chance).
Monotherapy
Using a single treatment on its own, without combining it with other therapies. In this context, microneedling monotherapy means microneedling without any additional topical medications.
Androgenetic Alopecia (AGA)
The most common form of hair loss, caused by a combination of genetic predisposition and the hormone DHT. It affects approximately 50% of men by age 50 and a significant proportion of women. Characterised by a receding hairline and crown thinning in men, and diffuse thinning in women.
Systematic Literature Search
A methodical and reproducible approach to finding all relevant research on a topic. Unlike a casual search, it follows strict protocols across multiple databases to ensure no important studies are missed — a critical step before conducting a meta-analysis.
Confounding Variable
A factor that is related to both the treatment and the outcome, which can distort the apparent effect if not accounted for. For example, study duration might confound the comparison between treatments if longer studies happen to use one treatment more than another. Multivariable regression controls for these confounders.
For more peer-reviewed studies on hair loss and copper peptide therapy, see our full research hub.
Frequently Asked Questions
Is a meta-analysis more reliable than a single clinical trial?
Yes. A meta-analysis sits at the top of the evidence hierarchy because it combines data from multiple independent studies. This overcomes the limitations of individual trials — small sample sizes, specific populations, or methodological quirks. When multiple studies conducted by different researchers in different countries all point in the same direction, the conclusion is far more robust than any single trial. This is why the finding that microneedling outperforms minoxidil (β = 12.29, p < 0.001) is so significant.
What does "β = 12.29" actually mean in practical terms?
The beta coefficient represents approximately 12.3 additional hairs per cm² attributable to microneedling compared to minoxidil, after controlling for other variables. A typical target area on the scalp might be 50–100 cm², so this could translate to 600–1,200 additional hairs in that zone. However, this is an average across diverse studies — individual results vary based on hair loss severity, protocol used, and genetic factors.
Why does less frequent microneedling seem to work better?
Microneedling works partly by triggering the body's wound healing cascade, which releases growth factors. This healing process takes time to complete — typically 5–7 days for the initial phase. If you microneedle again before the scalp has fully healed, you may interrupt the healing response and blunt the growth factor surge. Allowing adequate recovery time (10–14 days between sessions) may produce a stronger regenerative response with each treatment. Think of it as giving your body time to do its work.
Can I replace minoxidil with microneedling entirely?
The meta-analysis found that microneedling monotherapy outperforms minoxidil 5% (β = 12.29, p < 0.001), which suggests it can be effective on its own. However, the authors noted that few studies have tested microneedling as a standalone treatment — most combine it with topicals. The strongest evidence supports the combination approach, which adds another β = 7.63 on top. If you want to stop minoxidil, discuss it with your dermatologist and consider replacing it with other proven topical actives like copper peptide serums.
What needle depth does this meta-analysis recommend?
The studies included used needle depths ranging from 0.5 mm to 2.5 mm. While the meta-analysis did not identify a single "best" depth, the most commonly studied clinical depth is 1.0–1.5 mm. The Faghihi 2021 study found that 0.6 mm performed equally well as 1.2 mm, suggesting shallower depths may be sufficient for some patients. For at-home use, 0.25–0.5 mm is generally considered safe.
Does this evidence apply to women with hair loss?
Most studies in this meta-analysis focused on male androgenetic alopecia. However, the biological mechanisms by which microneedling works — growth factor release, stem cell activation, enhanced drug delivery — are not gender-specific. The Pei et al. 2024 meta-analysis included female participants and confirmed microneedling's superiority. Dedicated female-focused trials are still needed, but the available evidence is encouraging.
How long should I continue microneedling for hair loss?
The meta-analysis found that longer treatment duration positively influenced outcomes — meaning more weeks of treatment correlated with better hair count results. Most clinical trials run 12–24 weeks, but the data suggests continued benefit beyond that. Think of microneedling as an ongoing maintenance treatment rather than a one-time fix. Most dermatologists recommend an initial intensive phase (12–24 weeks) followed by less frequent maintenance sessions.
What topical treatments work best after microneedling?
This meta-analysis confirmed that minoxidil 5% adds significant benefit when combined with microneedling (β = 7.63, p < 0.05). Beyond minoxidil, other topical actives have shown promise in combination: copper peptides (Kuceki 2025) demonstrated significant results in resistant cases, platelet-rich plasma (PRP) has been studied in network meta-analyses, and GHK-Cu serums work through complementary mechanisms. The key principle is that microneedling enhances absorption of whatever you apply afterwards — so choose evidence-backed ingredients.
Original Study Citation
Gupta AK, Quinlan EM, Venkataraman M, Bamimore MA. Microneedling for Hair Loss. Journal of Cosmetic Dermatology. 2022;21(1):108-117. doi:10.1111/jocd.14525. PMID: 34714971.
How to cite this summary:
Hairgenetix Research Hub. "Microneedling for Hair Loss: What a Meta-Analysis of Multiple Studies Found (2022) — A Plain-Language Summary of Gupta et al. (2022)." Hairgenetix, 2025. Available at: https://hairgenetix.com/blogs/articles/microneedling-hair-loss-meta-analysis-gupta-2022
Last updated: March 2026 — Reviewed for accuracy against the original publication. Cross-references updated to include 2024 and 2025 meta-analyses.
About Hairgenetix Research Hub — Hairgenetix translates peer-reviewed hair science into plain-language summaries so you can make informed decisions about your hair care. Every article is based on published clinical research, reviewed by a physician (Dr. Esther Bodde, MD), and includes direct links to the original studies. Our copper peptide formulations are grounded in the same science we summarise here — including the microneedling synergy research documented by Gupta et al. and confirmed across multiple subsequent meta-analyses.
Advanced Daily Scalp Therapy for Stronger, Healthier Hair
🎯 Designed for hair loss and weak, thinning hair 🔬 Clinically Proven Ingredients 💧 Lightweight, non-greasy for easy daily use
The Hairgenetix Copper Peptide Serum is a powerful daily scalp treatment designed to stimulate hair follicles, reduce shedding, and support long-term hair health[2]. Infused with 10% GHK-Cu and 5% AHK-Cu copper peptides, this advanced formula works at the root level to improve follicle longevity, boost collagen production, and enhance scalp circulation[1]—creating the perfect environment for thicker, healthier hair growth.
Professional GHK-Cu Complete Follicle & Scalp Activation System
🚀 Maximizes Hair Growth Support at the Follicle Level 🛡️ Reduces Shedding While Strengthening Hair from Root to Tip 🌿 Optimizes Scalp Health for Thicker, Fuller-Looking Hair
Advanced hair care powered by GHK-Cu & AHK-Cu Copper Peptides. This professional shampoo, conditioner, and serum set works synergistically to cleanse, nourish, and activate the hair follicles at the root. The shampoo gently removes buildup and prepares the scalp, the conditioner restores moisture and resilience, and the targeted serum delivers concentrated copper peptides directly to the follicle environment.[1] Designed to help reduce shedding, improve hair density[2], and create optimal conditions for healthier, thicker-looking hair with consistent use.
Professional GHK-Cu Complete Follicle & Scalp Activation System
🚀 Maximizes Hair Growth Support at the Follicle Level 🛡️ Reduces Shedding While Strengthening Hair from Root to Tip 🌿 Optimizes Scalp Health for Thicker, Fuller-Looking Hair
Advanced hair care powered by GHK-Cu copper peptides. This professional shampoo and conditioner set works synergistically to cleanse, nourish, and strengthen the scalp and hair while supporting follicle regeneration and long-term hair growth.[1] Designed to help reduce shedding, improve hair density[2], and create the optimal environment for healthier, thicker-looking hair with consistent use.
Give the Gift of Science-Backed Hair Growth - Premium Copper Peptide Gift Box
🎁 Premium Gift-Ready Packaging - Complete & Ready to Give
🌟 Larger Sizes for Longer Results - 300ml Shampoo & Conditioner
✨ Complete 3-Step Copper Peptide Hair Care System
Searching for a copper peptide hair growth gift set that genuinely delivers? The Hairgenetix Copper Peptide Gift Box is a complete, research-backed hair care collection presented in premium gift box packaging - ready to give for birthdays, Christmas, or any occasion that deserves something special.
Inside this hair care gift box, you will find generous 300 ml bottles of our GHK-Cu and AHK-Cu infused Copper Peptide Shampoo and Conditioner - larger than the standard set - paired with the 30 ml Copper Peptide Hair Growth Serum. Every product is formulated around two of the most studied peptides in trichology research: GHK-Cu, which supports tissue remodelling and follicle health[2], and AHK-Cu, shown in laboratory studies to stimulate dermal papilla cell proliferation and support hair follicle growth[1].
Copper peptides work by activating the Wnt/beta-catenin signalling pathway in dermal papilla cells - the biological switch that drives the hair growth cycle. Regular use supports thicker-looking hair, a healthier scalp environment, and stronger follicles over time.
Whether you are buying for someone experiencing hair thinning or simply wanting to upgrade their hair care routine, this GHK-Cu gift set is a meaningful choice. Premium ingredients, larger 300 ml sizes, and a complete system - beautifully packaged and ready to make an impact.
🚀 Stimulates Hair Growth at the Follicle Level 🛡️ Reduces Hair Shedding & Strengthens Roots 🌿 Improves Scalp Health for Thicker, Healthier Hair
Advanced hair care powered by GHK-Cu copper peptides. This professional shampoo gently cleanses while supporting scalp regeneration, follicle health, and stronger hair growth.[1] Designed to help reduce shedding, improve hair density[2], and create the optimal environment for healthier, thicker-looking hair with every wash.
Advanced conditioning powered by GHK-Cu copper peptides. This professional conditioner deeply nourishes the hair and scalp while supporting follicle health, strength, and resilience.[1] Designed to reduce breakage, improve hair texture and density[2], and leave hair stronger, smoother, and healthier-looking with every use.
Microneedling for Hair Loss: What a Meta-Analysis of Multiple Studies Found (2022)
Why This Research Matters
By 2021, nearly a decade of clinical trials had been published testing microneedling for hair loss — from the landmark Dhurat 2013 study through dozens of subsequent trials. Each study told part of the story, but no single trial could answer the big picture question: across all available evidence, does microneedling really work, and how does it compare to established treatments?
That is exactly what Gupta et al. set out to answer. Their meta-analysis pooled data from multiple clinical trials and used multivariable linear regression — a statistical method that controls for confounding variables — to extract the clearest possible signal from the noise. The result was a definitive answer: microneedling is not just a useful add-on; it outperforms the gold-standard topical treatment (minoxidil 5%) as a standalone therapy.
This matters because it shifts microneedling from being seen as an "optional extra" to being recognised as a primary treatment option for androgenetic alopecia. For patients who cannot tolerate minoxidil, or who prefer a non-pharmaceutical approach, this meta-analysis provides the highest level of evidence supporting microneedling as a legitimate first-line treatment.
What The Researchers Did
The research team at the University of Toronto conducted a systematic literature search to identify all clinical trials that had tested microneedling for androgenetic alopecia (AGA). They followed established protocols to ensure no relevant studies were missed.
Once they had assembled the full body of evidence, they applied multivariable linear regression analysis to the pooled data. This is a sophisticated statistical approach that goes beyond simply averaging results — it analyses multiple variables simultaneously and isolates the independent effect of each treatment while controlling for factors that might distort the comparison.
The analysis compared three treatment approaches:
The researchers also examined moderating variables including needle depth, treatment frequency, and overall duration — asking not just whether microneedling works, but how to optimise it.
A meta-analysis is the highest level of clinical evidence. It pools data from multiple independent studies — each with its own patients, methods, and researchers — into a single statistical analysis. Think of it as combining the puzzle pieces from many different boxes to see the complete picture.
Multivariable regression adds an extra layer of rigour. Instead of simply averaging the results, it builds a mathematical model that accounts for multiple variables at once (e.g., needle depth, frequency, treatment duration, minoxidil use). This lets researchers isolate the effect of each variable independently. For example, it can determine whether microneedling's benefit is real even after accounting for differences in study duration or minoxidil concentration.
The beta coefficient (β) represents the size of the effect. A positive β means the treatment increased hair count; the larger the number, the greater the effect. The p-value tells us how confident we can be: p < 0.001 means there is less than a 0.1% chance the result occurred by random chance.
What They Found
1. Microneedling alone outperforms minoxidil 5%
This is the headline finding — and it is remarkable. Minoxidil has been the gold-standard topical treatment for androgenetic alopecia for over three decades. The fact that a physical treatment (creating micro-injuries in the scalp) outperforms the most widely prescribed topical medication challenges conventional treatment hierarchies.
The p-value of less than 0.001 makes this one of the most statistically robust findings in the hair loss treatment literature. There is less than a 0.1% probability that this result is due to chance.
2. Combining microneedling with minoxidil is even more effective
This confirms that microneedling and minoxidil have complementary mechanisms. Microneedling creates the micro-channels and triggers growth factor release, while minoxidil stimulates follicles through vasodilation and prolonged growth phase. Using both together produces an additive benefit — as demonstrated in the original Dhurat 2013 trial and now confirmed across multiple pooled studies.
3. Longer treatment duration improves outcomes
This suggests that microneedling's benefits are cumulative. Unlike some treatments that plateau quickly, microneedling appears to continue producing improvements with sustained use. This aligns with the biology: repeated stimulation of the wound healing cascade and growth factor release compounds over time.
4. Less frequent sessions may be more effective
This counterintuitive finding is biologically plausible. Microneedling triggers a wound healing cascade that requires time to complete. If sessions are too frequent, the scalp may not fully recover between treatments, potentially blunting the regenerative response. Allowing adequate healing time between sessions may produce a stronger growth factor surge with each treatment.
The Faghihi et al. 2021 study found similarly that more aggressive parameters are not necessarily better — shallower needle depths performed equally well as deeper ones.
Why Microneedling Works: The Science Behind the Results
1. Growth factor release through controlled injury
Every microneedling session creates thousands of micro-injuries that activate the body's wound healing cascade. This releases platelet-derived growth factor (PDGF), vascular endothelial growth factor (VEGF), epidermal growth factor (EGF), and fibroblast growth factor (FGF). These growth factors directly stimulate dermal papilla cells — the specialised cells that control the hair growth cycle — pushing dormant follicles into the active growth phase (anagen).
2. Stem cell activation via Wnt signalling
Microneedling activates the Wnt/β-catenin signalling pathway, a key molecular switch for hair follicle stem cell activation. This may explain why microneedling works even as a monotherapy: it recruits dormant stem cells through a mechanism entirely different from how minoxidil works, explaining why the two treatments are additive rather than redundant.
3. Enhanced drug delivery
For combination therapy, microneedling creates temporary channels through the stratum corneum (skin barrier), allowing topical treatments to penetrate 5–10× deeper into the follicle than surface application. This is why adding minoxidil to microneedling produces additional benefit (β = 7.63): the microneedling literally delivers more of the drug to where it needs to go.
4. Neovascularisation
The healing response stimulates new blood vessel formation (angiogenesis) around hair follicles, improving nutrient delivery. This complements both minoxidil's vasodilatory effect and the blood vessel-promoting properties of peptides like GHK-Cu, which affects 31.2% of human genes including those governing vascular remodelling.
Putting the Numbers in Context
The beta coefficients from this meta-analysis represent the independent effect of each treatment after controlling for confounding variables. Here is how to interpret them:
Combined, these findings suggest that microneedling + minoxidil produces approximately 20 more hairs per cm² than minoxidil alone — a finding broadly consistent with individual trials like Dhurat et al. (2013), which found a 4× improvement, and Pei et al. (2024), which confirmed statistically significant superiority across 1,458 patients.
The regression coefficients are more conservative than individual study results because they control for confounding variables. The Dhurat study's dramatic +91.4 vs +22.2 hairs/cm² result likely reflects specific study conditions (population, needle depth, compliance). The meta-analysis distils the average effect across diverse conditions — providing a more generalisable estimate of what a typical patient might expect.
How This Study Compares to Other Meta-Analyses
Every meta-analysis conducted since 2022 has confirmed the same conclusion: microneedling, alone or in combination with topical treatment, produces significantly better outcomes than topical treatment alone. The consistency of this finding across different research groups, statistical methods, and patient populations makes it one of the most robust conclusions in the hair loss treatment literature.
Important: Microneedling at clinical depths (1.0+ mm) should be performed by or under the guidance of a healthcare professional. At-home devices typically use shorter needles (0.25–0.5 mm). Always consult your dermatologist about the appropriate protocol for your situation.
Research Limitations
What This Means for Your Hair
This meta-analysis provides the strongest evidence to date that microneedling should be considered a primary treatment for androgenetic alopecia — not just an add-on to existing therapies. Here is what this means in practical terms:
If you are currently using minoxidil alone: Adding microneedling is likely to significantly improve your results. The combination effect (β = 7.63) is statistically significant and has been confirmed by every subsequent meta-analysis.
If you cannot use or tolerate minoxidil: Microneedling as monotherapy may be a viable alternative. The meta-analysis found it outperforms minoxidil 5% (β = 12.29, p < 0.001), though more monotherapy studies are needed to fully establish optimal standalone protocols.
If you want to optimise your microneedling protocol: The data suggests that longer treatment duration (3–6 months minimum) and less aggressive session frequency (fortnightly rather than weekly) may actually produce better results than trying to do more, more often.
For the most evidence-based approach, combine microneedling with proven topical formulations. The micro-channels created by microneedling dramatically enhance absorption of active ingredients. Research on AHK-Cu copper peptides and GHK-Cu shows these ingredients work through complementary biological pathways, and the Kuceki et al. 2025 study specifically demonstrated that combining microneedling with copper peptide formulations produced significant improvement in treatment-resistant alopecia.
Key Terms Explained
Further Reading
For more peer-reviewed studies on hair loss and copper peptide therapy, see our full research hub.
Frequently Asked Questions
Is a meta-analysis more reliable than a single clinical trial?
Yes. A meta-analysis sits at the top of the evidence hierarchy because it combines data from multiple independent studies. This overcomes the limitations of individual trials — small sample sizes, specific populations, or methodological quirks. When multiple studies conducted by different researchers in different countries all point in the same direction, the conclusion is far more robust than any single trial. This is why the finding that microneedling outperforms minoxidil (β = 12.29, p < 0.001) is so significant.
What does "β = 12.29" actually mean in practical terms?
The beta coefficient represents approximately 12.3 additional hairs per cm² attributable to microneedling compared to minoxidil, after controlling for other variables. A typical target area on the scalp might be 50–100 cm², so this could translate to 600–1,200 additional hairs in that zone. However, this is an average across diverse studies — individual results vary based on hair loss severity, protocol used, and genetic factors.
Why does less frequent microneedling seem to work better?
Microneedling works partly by triggering the body's wound healing cascade, which releases growth factors. This healing process takes time to complete — typically 5–7 days for the initial phase. If you microneedle again before the scalp has fully healed, you may interrupt the healing response and blunt the growth factor surge. Allowing adequate recovery time (10–14 days between sessions) may produce a stronger regenerative response with each treatment. Think of it as giving your body time to do its work.
Can I replace minoxidil with microneedling entirely?
The meta-analysis found that microneedling monotherapy outperforms minoxidil 5% (β = 12.29, p < 0.001), which suggests it can be effective on its own. However, the authors noted that few studies have tested microneedling as a standalone treatment — most combine it with topicals. The strongest evidence supports the combination approach, which adds another β = 7.63 on top. If you want to stop minoxidil, discuss it with your dermatologist and consider replacing it with other proven topical actives like copper peptide serums.
What needle depth does this meta-analysis recommend?
The studies included used needle depths ranging from 0.5 mm to 2.5 mm. While the meta-analysis did not identify a single "best" depth, the most commonly studied clinical depth is 1.0–1.5 mm. The Faghihi 2021 study found that 0.6 mm performed equally well as 1.2 mm, suggesting shallower depths may be sufficient for some patients. For at-home use, 0.25–0.5 mm is generally considered safe.
Does this evidence apply to women with hair loss?
Most studies in this meta-analysis focused on male androgenetic alopecia. However, the biological mechanisms by which microneedling works — growth factor release, stem cell activation, enhanced drug delivery — are not gender-specific. The Pei et al. 2024 meta-analysis included female participants and confirmed microneedling's superiority. Dedicated female-focused trials are still needed, but the available evidence is encouraging.
How long should I continue microneedling for hair loss?
The meta-analysis found that longer treatment duration positively influenced outcomes — meaning more weeks of treatment correlated with better hair count results. Most clinical trials run 12–24 weeks, but the data suggests continued benefit beyond that. Think of microneedling as an ongoing maintenance treatment rather than a one-time fix. Most dermatologists recommend an initial intensive phase (12–24 weeks) followed by less frequent maintenance sessions.
What topical treatments work best after microneedling?
This meta-analysis confirmed that minoxidil 5% adds significant benefit when combined with microneedling (β = 7.63, p < 0.05). Beyond minoxidil, other topical actives have shown promise in combination: copper peptides (Kuceki 2025) demonstrated significant results in resistant cases, platelet-rich plasma (PRP) has been studied in network meta-analyses, and GHK-Cu serums work through complementary mechanisms. The key principle is that microneedling enhances absorption of whatever you apply afterwards — so choose evidence-backed ingredients.
Gupta AK, Quinlan EM, Venkataraman M, Bamimore MA. Microneedling for Hair Loss. Journal of Cosmetic Dermatology. 2022;21(1):108-117. doi:10.1111/jocd.14525. PMID: 34714971.
Hairgenetix Research Hub. "Microneedling for Hair Loss: What a Meta-Analysis of Multiple Studies Found (2022) — A Plain-Language Summary of Gupta et al. (2022)." Hairgenetix, 2025. Available at: https://hairgenetix.com/blogs/articles/microneedling-hair-loss-meta-analysis-gupta-2022